Comparative Safety of Periablation Anticoagulation Strategies for Atrial Fibrillation: Data from a Large Multicenter Study-Reference-Cited by-同舟云学术

Comparative Safety of Periablation Anticoagulation Strategies for Atrial Fibrillation: Data from a Large Multicenter Study

Published:2014-05-04 Issue:6 Volume:37 Page:665-673
ISSN:0147-8389
Container-title:Pacing and Clinical Electrophysiology
language:en
Short-container-title:Pacing and Clinical Electrophysiology

Author:

ARSHAD AYSHA¹,JOHNSON CHRISTOPHER K.¹,MITTAL SUNEET¹,BUCH ERIC²,HAMAM ISMAIL³,TRAN THANH⁴,SHAW RICHARD E.¹,MUSAT DAN¹,PREMINGER MARK¹,SICHROVSKY TINA¹,HERWEG BENGT⁴,SHIVKUMAR KALYANAM²,HUMMEL JOHN³,STEINBERG JONATHAN S.¹

Affiliation:

1. Arrhythmia Institute; Valley Health System; New York New York and Ridgewood New Jersey

2. Cardiology Division, University of California; Los Angeles Los Angeles California

3. Department of Cardiology; Ohio State University; Columbus Ohio

4. Department of Cardiology University of South Florida; Tampa Florida

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pace.12401/fullpdf

Reference26 articles.

1. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: An update of the 2010 ESC guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association;Camm;Europace,2012

2. Characteristics of patients undergoing atrial fibrillation ablation: Trends over a seven-year period 1999-2005;Gerstenfeld;J Cardiovasc Electrophysiol,2007

3. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation;Cappato;Circ Arrhythm Electrophysiol,2010

4. Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation;Lip;Europace,2012

5. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society;Calkins;Heart Rhythm,2012

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Day Interruption of NOAC Is Associated with Low Risk of Periprocedural Adverse Events during Pulmonary Vein Isolation If Combined with Left Atrial Thrombus Exclusion with Computed Tomography;Life;2024-01-17

2. One day interruption of NOAC is associated with low risk of periprocedural adverse events during pulmonary vein isolation if combined with left atrial thrombus exclusion with computed tomography;2023-03-17

3. Contemporary Management of Direct Oral Anticoagulants During Cardioversion and Ablation for Nonvalvular Atrial Fibrillation;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2019-01

4. META-ANALYSIS OF COMPLICATIONS IN PATIENTS UNDERGOING PROCEDURES WITH UNINTERRUPTED ANTICOAGULATION COMPARED WITH BRIDGING ANTICOAGULATION;ACTA MEDICA MEDITERR;2019

5. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures;Cardiology in Review;2018-09